US Patent Issued to Bristol-Myers Squibb on Jan. 20 for "Salts/cocrystals of (R)-N-(4-chlorophenyl-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide" (New Jersey, New York Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,783, issued on Jan. 20, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Salts/cocrystals of (R)-N-(4-chlorophenyl-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide" was invented by Tamar I. Rosenbaum (Princeton, N.J.) and Melanie Janelle Bevill (Albany, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to amorphous and crystalline forms of (R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoro-quinolin-4-yl)cyclohexyl)propanamide and its salts/cocrystals, solvates, and/or hydrates, processes for their production, pharmaceutical compositions comprising them, and methods of treatment using them."

The pate...